<p><sup>a</sup>Number of methyl groups on Lys-561 in HSPA1, calculated from the data in the three previous columns according to the following formula: (Me1 + 2∙Me2 + 3∙Me3)/100</p><p><sup>b</sup>Patient was alive with disease at the end of the follow-up period (110 mo), and was therefore censored in OS curve (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0140168#pone.0140168.g003" target="_blank">Fig 3A</a>)</p><p><sup>c</sup>Patient was alive without disease after the end of the follow-up period (132 mo for OS and 127 mo for PFS), and was therefore censored in OS and PFS curves (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0140168#pone.0140168.g003" target="_blank">Fig 3</a>)</p><p>HSPA1 met...
<p>Kaplan-Meier survival estimates of overall survival for methylation levels in peripheral blood of...
<p>Integrative genomics viewer (IGV) plots showing m<sup>6</sup>A methylated peaks for <i>HSPA1B</i>...
<p>A) Green Line: 5-year disease-free survival of patients with normal LINE-1 methylation(76%) Blue ...
Cellular proteins are subject to frequent methylation on lysine residues, introduced by spe-cific me...
<p>(A) Quantitative mass spectrometry analysis of HSPA1-Lys561 methylation. Samples were analyzed as...
<div><p>Cellular proteins are subject to frequent methylation on lysine residues, introduced by spec...
<p>Patients with <i>RASSF1A</i> promoter methylation showed poorer over-all survival (A) (<i>P</i> <...
<p>Kaplan-Meier survival analysis of overall survival of 526 HNSCC patients stratified according to ...
<p>The Kaplan-Meier curves for genes (DSP, EPHB6, HCK, IL18, IRAK3 and KIT) whose hypermethylation w...
A) Correlation of LINE-1 hypomethylation and poor survival in HCC. In compared to without methylatio...
<p>Kaplan-Meier survival analysis of overall survival in p16-positive (A), p16-negative (B), and HPV...
<p>Overall survival was compared according to methylation status of <i>HS3ST2</i> in 193 node-negati...
<p>The curves show CF-free survival of patients from the low (LM, <15% <i>GSTP1</i> methylation), mo...
<p>(<b>A</b>) HS3ST2 mRNA levels were first compared quantitatively between 26 fresh-frozen tumor ti...
<p>The 5 year EFS (A) and OS (B) for 43 T-ALL samples analyzed for CpG methylation and 32 T-ALL pati...
<p>Kaplan-Meier survival estimates of overall survival for methylation levels in peripheral blood of...
<p>Integrative genomics viewer (IGV) plots showing m<sup>6</sup>A methylated peaks for <i>HSPA1B</i>...
<p>A) Green Line: 5-year disease-free survival of patients with normal LINE-1 methylation(76%) Blue ...
Cellular proteins are subject to frequent methylation on lysine residues, introduced by spe-cific me...
<p>(A) Quantitative mass spectrometry analysis of HSPA1-Lys561 methylation. Samples were analyzed as...
<div><p>Cellular proteins are subject to frequent methylation on lysine residues, introduced by spec...
<p>Patients with <i>RASSF1A</i> promoter methylation showed poorer over-all survival (A) (<i>P</i> <...
<p>Kaplan-Meier survival analysis of overall survival of 526 HNSCC patients stratified according to ...
<p>The Kaplan-Meier curves for genes (DSP, EPHB6, HCK, IL18, IRAK3 and KIT) whose hypermethylation w...
A) Correlation of LINE-1 hypomethylation and poor survival in HCC. In compared to without methylatio...
<p>Kaplan-Meier survival analysis of overall survival in p16-positive (A), p16-negative (B), and HPV...
<p>Overall survival was compared according to methylation status of <i>HS3ST2</i> in 193 node-negati...
<p>The curves show CF-free survival of patients from the low (LM, <15% <i>GSTP1</i> methylation), mo...
<p>(<b>A</b>) HS3ST2 mRNA levels were first compared quantitatively between 26 fresh-frozen tumor ti...
<p>The 5 year EFS (A) and OS (B) for 43 T-ALL samples analyzed for CpG methylation and 32 T-ALL pati...
<p>Kaplan-Meier survival estimates of overall survival for methylation levels in peripheral blood of...
<p>Integrative genomics viewer (IGV) plots showing m<sup>6</sup>A methylated peaks for <i>HSPA1B</i>...
<p>A) Green Line: 5-year disease-free survival of patients with normal LINE-1 methylation(76%) Blue ...